MedPath

Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer

Not Applicable
Recruiting
Conditions
Endodontic Disease
Endodontically Treated Teeth
Interventions
Other: BioRoot RCS® root canal sealer
Other: AH Plus® root canal sealer
Registration Number
NCT04528979
Lead Sponsor
Juan Gonzalo Olivieri
Brief Summary

This study is a prospective randomized controlled study of patients who come to the University. The aim is to evaluate the success rate of treatment and retreatment of canals using BioRoot ™ RCS cement compared with AH Plus up to 6 years of follow-up. The null hypothesis is that there will be no statistically significant differences in rates of successful treatment of root canals filled with BioRoot ™ RCS compared to gutta-percha and AH Plus sealer.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Patients that demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and received a signed and dated copy of the informed consent form.
  • Understands and is willing to comply with all study procedures and restrictions.
  • Not presence of clinically significant and relevant abnormalities of clinical history or oral examination.
  • Diagnosis of irreversible pulpitis or apical symptomatic / asymptomatic periodontitis.
  • Retreatment cases due to an endodontic failure.
  • Single or bi-radicular teeth.
Exclusion Criteria
  • General: Patients with systemic diseases, diabetes, immunocompromised and pregnant women, or any clinically significant or relevant oral abnormalities.
  • Specific: root resorption, root fractures, impossibility of restoration and cases were primary or secondary root canal treatment is not the treatment of choice.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Secondary root canal treatmentBioRoot RCS® root canal sealerSecondary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers
Primary root canal treatmentBioRoot RCS® root canal sealerPrimary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers
Primary root canal treatmentAH Plus® root canal sealerPrimary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers
Secondary root canal treatmentAH Plus® root canal sealerSecondary root canal treatment sealed with guttapercha and AH Plus® or BioRoot RCS® root canal sealers
Primary Outcome Measures
NameTimeMethod
Clinical post-operative pain48 hours post treatment

VAS score of patient' level of pain, from no pain to extreme pain

Clinical signs or symptoms of periapical disease6 years

Absence/presence of clinical signs or symptoms of periapical disease

Radiographic periapical healing6 years

Absence/presence of radiographic apical periodontitis + PAI changes when compared with post-treatment radiograph

Secondary Outcome Measures
NameTimeMethod
Correlation of prognostic factors and clinical signs or symptoms of periapical disease6 years

Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with having clinical signs or symptoms of periapical disease

Correlation of prognostic factors and radiographic periapical healing6 years

Correlation of Pre-treatment symptomatology, post-operative pain, radiographic periapical lesion size, being an abutment, and presence of antagonist with radiographic periapical healing

Trial Locations

Locations (1)

Universitat Internacional de Catalunya

🇪🇸

Sant Cugat Del Vallès, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath